NewsNation on MSN10h
Study links Wegovy to increased hair loss riskA new study from the University of British Columbia says an ingredient used in popular weight-loss drugs could have side effects linked to hair loss. Semaglutide, the main ingredient in Ozempic and ...
Zacks Investment Research on MSN15h
Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This ...
Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...
Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback